{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:57:40Z","timestamp":1790859460451,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["24616"],"award-info":[{"award-number":["24616"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12325-025-03121-x","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:37:22Z","timestamp":1739504242000},"page":"1729-1744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification"],"prefix":"10.1007","volume":"42","author":[{"given":"Kamran","family":"Bagheri Lankarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-9989","authenticated-orcid":false,"given":"Mohamad","family":"Jamalinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Taghi","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ardekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"2","key":"3121_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169\u201377.","journal-title":"J Epidemiol Glob Health"},{"key":"3121_CR2","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021). Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2024."},{"issue":"4","key":"3121_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jcct.2015.03.015","volume":"9","author":"K Alluri","year":"2015","unstructured":"Alluri K, McEvoy JW, Dardari ZA, et al. Distribution and burden of newly detected coronary artery calcium: results from the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr. 2015;9(4):337-44.e1.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"3121_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.amjcard.2022.12.014","volume":"191","author":"R Dudum","year":"2023","unstructured":"Dudum R, Dardari ZA, Feldman DI, et al. Coronary artery calcium dispersion and cause-specific mortality. Am J Cardiol. 2023;191:76\u201383.","journal-title":"Am J Cardiol"},{"issue":"41","key":"3121_CR5","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1093\/eurheartj\/ehy534","volume":"39","author":"LJ Shaw","year":"2018","unstructured":"Shaw LJ, Min JK, Nasir K, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018;39(41):3727\u201335.","journal-title":"Eur Heart J"},{"issue":"20","key":"3121_CR6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"11","key":"3121_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903\u201313.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"3121_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/apt.17617","volume":"58","author":"M Jamalinia","year":"2023","unstructured":"Jamalinia M, Zare F, Lankarani KB. Systematic review and meta-analysis: association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2023;58(4):384\u201394.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3121_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/apt.17869","volume":"59","author":"M Jamalinia","year":"2024","unstructured":"Jamalinia M, Zare F, Noorizadeh K, Bagheri LK. Systematic review with meta-analysis: steatosis severity and subclinical atherosclerosis in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024;59(4):445\u201358.","journal-title":"Aliment Pharmacol Ther"},{"issue":"14","key":"3121_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030269","volume":"12","author":"D Miyamori","year":"2023","unstructured":"Miyamori D, Tanaka M, Sato T, et al. Coexistence of metabolic dysfunction-associated fatty liver disease and chronic kidney disease is a more potent risk factor for ischemic heart disease. J Am Heart Assoc. 2023;12(14): e030269.","journal-title":"J Am Heart Assoc"},{"issue":"10250","key":"3121_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565\u201382.","journal-title":"Lancet"},{"issue":"1","key":"3121_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","volume":"19","author":"M Balakrishnan","year":"2021","unstructured":"Balakrishnan M, Patel P, Dunn-Valadez S, et al. Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(1):61-71.e15.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"3121_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MCA.0000000000000999","volume":"32","author":"L Cherukuri","year":"2021","unstructured":"Cherukuri L, Birudaraju D, Budoff MJ. Coronary artery calcium score: pivotal role as a predictor for detecting coronary artery disease in symptomatic patients. Coron Artery Dis. 2021;32(6):578\u201385.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"3121_CR14","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.249008","volume":"6","author":"LE Burkard-Mandel","year":"2024","unstructured":"Burkard-Mandel LE. Prediction of major adverse cardiovascular events in patients with chest pain using coronary artery calcium score. Radiol Imaging Cancer. 2024;6(3):e249008.","journal-title":"Radiol Imaging Cancer"},{"issue":"8","key":"3121_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.ajt.2023.05.001","volume":"23","author":"MB Nielsen","year":"2023","unstructured":"Nielsen MB, Dahl JN, Laursen R, et al. In a real-life setting, risk factors, coronary artery calcium score, and coronary stenosis at computed tomography angiography are associated with major adverse cardiovascular events and all-cause mortality among kidney transplant candidates. Am J Transplant. 2023;23(8):1194\u2013208.","journal-title":"Am J Transplant"},{"issue":"11","key":"3121_CR16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/ehjci\/jeac082","volume":"23","author":"RJH Miller","year":"2022","unstructured":"Miller RJH, Han D, Singh A, et al. Relationship between ischaemia, coronary artery calcium scores, and major adverse cardiovascular events. Eur Heart J Cardiovasc Imaging. 2022;23(11):1423\u201333.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"3121_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.14740\/jocmr4335","volume":"12","author":"Y Shiga","year":"2020","unstructured":"Shiga Y, Morii J, Idemoto Y, et al. A coronary artery calcium score of zero in patients who have undergone coronary computed tomography angiography is associated with freedom from major adverse cardiovascular events. J Clin Med Res. 2020;12(10):662\u20137.","journal-title":"J Clin Med Res"},{"issue":"11","key":"3121_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"8","key":"3121_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"3121_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"11","key":"3121_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3121_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol. 2009;51(6):1061\u20137.","journal-title":"J Hepatol"},{"issue":"6","key":"3121_CR23","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"4","key":"3121_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3121_CR25","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027\u201337.","journal-title":"Lancet Glob Health"},{"issue":"Suppl E","key":"3121_CR26","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1093\/eurheartj\/suaa068","volume":"22","author":"L Gatto","year":"2020","unstructured":"Gatto L, Prati F. Subclinical atherosclerosis: how and when to treat it? Eur Heart J Suppl. 2020;22(Suppl E):E87-E90.","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"3121_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"25 Suppl 2","key":"3121_CR28","first-page":"S49","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49\u201373.","journal-title":"Circulation"},{"issue":"6","key":"3121_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/apt.17637","volume":"58","author":"SZ Kuo","year":"2023","unstructured":"Kuo SZ, Cepin S, Bergstrom J, et al. Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type\u00a02 diabetes. Aliment Pharmacol Ther. 2023;58(6):585\u201392.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"3121_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/liv.14472","volume":"40","author":"KT Brunner","year":"2020","unstructured":"Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing liver fat is associated with progression of cardiovascular risk factors. Liver Int. 2020;40(6):1339\u201343.","journal-title":"Liver Int"},{"issue":"6","key":"3121_CR31","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.cpcardiol.2024.102569","volume":"49","author":"N Nso","year":"2024","unstructured":"Nso N, Mergen D, Ikram M, et al. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: a comprehensive meta-analysis. Curr Probl Cardiol. 2024;49(6):102569.","journal-title":"Curr Probl Cardiol"},{"key":"3121_CR32","doi-asserted-by":"crossref","unstructured":"Danpanichkul P, Suparan K, Kim D, Wijarnpreecha K. What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: from bench to bedside. J Clin Med. 2024;13(1):278.","DOI":"10.3390\/jcm13010278"},{"issue":"12","key":"3121_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jcmg.2016.03.001","volume":"9","author":"MJ Blaha","year":"2016","unstructured":"Blaha MJ, Budoff MJ, Tota-Maharaj R, et al. Improving the CAC score by addition of regional measures of calcium distribution: multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging. 2016;9(12):1407\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"3121_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcct.2019.03.011","volume":"14","author":"O Dzaye","year":"2020","unstructured":"Dzaye O, Dudum R, Mirbolouk M, et al. Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): dual importance of CAC score and CAC distribution from the coronary artery calcium (CAC) consortium. J Cardiovasc Comput Tomogr. 2020;14(1):12\u20137.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"9","key":"3121_CR35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.amjcard.2015.01.555","volume":"115","author":"R Tota-Maharaj","year":"2015","unstructured":"Tota-Maharaj R, Joshi PH, Budoff MJ, et al. Usefulness of regional distribution of coronary artery calcium to improve the prediction of all-cause mortality. Am J Cardiol. 2015;115(9):1229\u201334.","journal-title":"Am J Cardiol"},{"issue":"8","key":"3121_CR36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcmg.2017.05.007","volume":"10","author":"MJ Blaha","year":"2017","unstructured":"Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M. Coronary artery calcium scoring: is it time for a change in methodology? JACC Cardiovasc Imaging. 2017;10(8):923\u201337.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"3121_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13101","volume":"49","author":"YY Hyun","year":"2019","unstructured":"Hyun YY, Kim H, Oh K-H, et al. eGFR and coronary artery calcification in chronic kidney disease. Eur J Clin Investig. 2019;49(6):e13101.","journal-title":"Eur J Clin Investig"},{"issue":"24","key":"3121_CR38","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982\u20132004.","journal-title":"Circulation"},{"issue":"10","key":"3121_CR39","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed N, Sohrabi M, Ajdarkosh H, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023\u201330.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3121_CR40","first-page":"1275","volume":"43","author":"B Amirkalali","year":"2014","unstructured":"Amirkalali B, Poustchi H, Keyvani H, et al. Prevalence of non-alcoholic fatty liver disease and its predictors in North of Iran. Iran J Public Health. 2014;43(9):1275\u201383.","journal-title":"Iran J Public Health"},{"issue":"6","key":"3121_CR41","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","volume":"34","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291\u2013326.","journal-title":"Adv Ther"},{"issue":"4","key":"3121_CR42","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"25","key":"3121_CR43","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506\u201332.","journal-title":"Circulation"},{"key":"3121_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.amjcard.2021.03.025","volume":"149","author":"BS Kim","year":"2021","unstructured":"Kim BS, Chan N, Hsu G, et al. Sex differences in coronary arterial calcification in symptomatic patients. Am J Cardiol. 2021;149:16\u201320.","journal-title":"Am J Cardiol"},{"issue":"1","key":"3121_CR45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41598-020-57894-y","volume":"10","author":"SH Kim","year":"2020","unstructured":"Kim SH, Park HY, Lee HS, et al. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity. Sci Rep. 2020;10(1):1025.","journal-title":"Sci Rep"},{"issue":"3","key":"3121_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.20517\/mtod.2024.34","volume":"4","author":"M Jamalinia","year":"2024","unstructured":"Jamalinia M, Lonardo A. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge. Metab Target Organ Damage. 2024;4(3):23.","journal-title":"Metab Target Organ Damage"},{"key":"3121_CR47","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Kar A, Khatun N, Datta P, Biswas A, Barik S. Familiarity breeds strategy: in silico untangling of the molecular complexity on course of autoimmune liver disease-to-hepatocellular carcinoma transition predicts novel transcriptional signatures. Cells. 2021;10(8):1917.","DOI":"10.3390\/cells10081917"},{"issue":"8","key":"3121_CR48","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/life13081669","volume":"13","author":"Y Dimitroglou","year":"2023","unstructured":"Dimitroglou Y, Aggeli C, Theofilis P, et al. Novel anti-inflammatory therapies in coronary artery disease and acute coronary syndromes. Life. 2023;13(8):1669.","journal-title":"Life"},{"issue":"10","key":"3121_CR49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/17512433.2023.2259306","volume":"16","author":"A Lonardo","year":"2023","unstructured":"Lonardo A. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers. Expert Rev Clin Pharmacol. 2023;16(10):891\u2013911.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"3121_CR50","doi-asserted-by":"crossref","unstructured":"Kami\u0144ska MS, Schneider-Matyka D, Rachubi\u0144ska K, Panczyk M, Grochans E, Cybulska AM. Menopause predisposes women to increased risk of cardiovascular disease. J Clin Med. 2023;12(22):7058.","DOI":"10.3390\/jcm12227058"},{"issue":"1","key":"3121_CR51","first-page":"7","volume":"1","author":"S Ballestri","year":"2021","unstructured":"Ballestri S, Mantovani A, Byrne CD, Lonardo A, Targher G. Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies. Metab Target Organ Damage. 2021;1(1):7.","journal-title":"Metab Target Organ Damage"},{"issue":"3","key":"3121_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.20517\/mtod.2023.21","volume":"3","author":"S Ballestri","year":"2023","unstructured":"Ballestri S, Lonardo A. Ultrasonographic fatty liver indicator (US-FLI): a reliable biomarker for non-invasive NAFLD stratification. Metab Target Organ Damage. 2023;3(3):13.","journal-title":"Metab Target Organ Damage"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03121-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:09:07Z","timestamp":1743106147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03121-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3121"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03121-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amedeo Lonardo is an Editorial Board member of\n                      Advances in Therapy\n                      . Amedeo Lonardo was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The remaining authors, including Kamran Bagheri Lankarani, Mohamad Jamalinia, Fatemeh Zare, Seyed Taghi Heydari, and Ali Ardekani, have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments and was approved by the Institutional Review Board of Shiraz University of Medical Sciences (SUMS) (approval number IR.SUMS.REC.1401.042). Written informed consent was obtained from all patients prior to their enrollment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}